Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ltx-315
1. Ltx-315
2. Ruxotemitide
3. 1345407-05-7
4. Kkwwkkwdipk-nh2
5. Ltx 315
6. Kkwwkkw-.beta.-phenyl-fk-nh2
7. 75fbl12iz7
8. Ruxotemitide [inn]
9. Unii-75fbl12iz7
10. Ltx315
11. Chembl4297628
12. Ltx 315 [who-dd]
13. K-k-w-w-k-k-w-dip-k-nh2
14. S8199
15. Ccg-270681
16. Cs-6979
17. Db12748
18. Bs-15278
19. Hy-19894
20. D84062
21. Q27266383
22. (s)-2,6-diamino-n-((5s,8s,11s,14s,17s,20s,23s,26s)-11,20,23-tris((1h-indol-3-yl)methyl)-1,30-diamino-14,17-bis(4-aminobutyl)-8-benzhydryl-5-carbamoyl-7,10,13,16,19,22,25-heptaoxo-6,9,12,15,18,21,24-heptaazatriacontan-26-yl)hexanamide
23. L-lysinamide, L-lysyl-l-lysyl-l-tryptophyl-l-tryptophyl-l-lysyl-l-lysyl-l-tryptophyl-.beta.-phenyl-l-phenylalanyl-
| Molecular Weight | 1439.8 g/mol |
|---|---|
| Molecular Formula | C78H106N18O9 |
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 18 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 46 |
| Exact Mass | 1438.83901703 g/mol |
| Monoisotopic Mass | 1438.83901703 g/mol |
| Topological Polar Surface Area | 479 Ų |
| Heavy Atom Count | 105 |
| Formal Charge | 0 |
| Complexity | 2670 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 9 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
99
PharmaCompass offers a list of Ruxotemitide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ruxotemitide manufacturer or Ruxotemitide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ruxotemitide manufacturer or Ruxotemitide supplier.
PharmaCompass also assists you with knowing the Ruxotemitide API Price utilized in the formulation of products. Ruxotemitide API Price is not always fixed or binding as the Ruxotemitide Price is obtained through a variety of data sources. The Ruxotemitide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ruxotemitide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ruxotemitide, including repackagers and relabelers. The FDA regulates Ruxotemitide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ruxotemitide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ruxotemitide supplier is an individual or a company that provides Ruxotemitide active pharmaceutical ingredient (API) or Ruxotemitide finished formulations upon request. The Ruxotemitide suppliers may include Ruxotemitide API manufacturers, exporters, distributors and traders.
Ruxotemitide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ruxotemitide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ruxotemitide GMP manufacturer or Ruxotemitide GMP API supplier for your needs.
A Ruxotemitide CoA (Certificate of Analysis) is a formal document that attests to Ruxotemitide's compliance with Ruxotemitide specifications and serves as a tool for batch-level quality control.
Ruxotemitide CoA mostly includes findings from lab analyses of a specific batch. For each Ruxotemitide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ruxotemitide may be tested according to a variety of international standards, such as European Pharmacopoeia (Ruxotemitide EP), Ruxotemitide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ruxotemitide USP).
